RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness

计划入组 21 人 · 首次发布于 2008 年 3 月 10 日

Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract

计划入组 60 人 · 首次发布于 2014 年 10 月 1 日

An Epidemiological Study to Evaluate the RSV-Associated Lower Respiratory Track in Infections in Infants

计划入组 2,048 人 · 首次发布于 2006 年 8 月 29 日

undisclosed respiratory program (respiratory disease)

undisclosed respiratory disease program (respiratory diseases)

Nirsevimab(Beyfortus)

Rx

TRACT Therapeutics, Inc.

United States

RSV Therapeutics LLC

Associated Capital

United States

Three RSV Vaccines Now Available for Older Adults as FDA Approves Moderna's mRESVIA

Health Canada Approves Moderna's mRNA RSV Vaccine for Older Adults

FDA Approves Abrysvo for RSV Prevention in Adults Aged 18-59 at Increased Risk